CD276 and pancreatic ductal adenocarcinoma: To evaluate the in vivo efficacy of fully human B7-H3 CAR T cells, we utilized an orthotopic xenograft model of pancreatic ductal adenocarcinoma (PDAC), a highly treatment-resistant cancer.